EnteroMedics' IPO

EnteroMedics raised a round of funding on November 14, 2007. Investors include Public.

EnteroMedics (NASDAQ: ETRM) has developed vBloc® vagal blocking therapy, a unique, broadly patented therapeutic approach to treat a range of gastrointestinal and metabolic diseases. vBloc® is a firs…

Articles about EnteroMedics' IPO: